Literature DB >> 8486768

Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells.

J A Halperin1, A Taratuska, A Nicholson-Weller.   

Abstract

The membrane attack complex of complement (MAC) can induce reversible changes in cell membrane permeability resulting in significant but transient intracellular ionic changes in the absence of cell lysis. Because ion fluxes and cytosolic ionic changes are integral steps in the signaling cascade initiated when growth factors bind to their receptors, we hypothesized that the MAC-induced reversible changes in membrane permeability could stimulate cell proliferation. Using purified terminal complement components we have documented a mitogenic effect of the MAC for quiescent murine 3T3 cells. The MAC enhances the mitogenic effects of serum and PDGF, and also stimulates cell proliferation in the absence of other exogenous growth factors. MAC-induced mitogenesis represents a novel effect of the terminal complement complex that could contribute to focal tissue repair or pathological cell proliferation locally at sites of complement activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486768      PMCID: PMC288194          DOI: 10.1172/JCI116418

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Complement C5b-9-stimulated platelet secretion is associated with a Ca2+-initiated activation of cellular protein kinases.

Authors:  T Wiedmer; B Ando; P J Sims
Journal:  J Biol Chem       Date:  1987-10-05       Impact factor: 5.157

2.  Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis.

Authors:  E W Rauterberg; H M Lieberknecht; A M Wingen; E Ritz
Journal:  Kidney Int       Date:  1987-03       Impact factor: 10.612

3.  Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of the reacylation of liberated arachidonic acid.

Authors:  G M Hänsch; D Gemsa; K Resch
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

4.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

5.  Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.

Authors:  J L Stewart; J B Monahan; A Brickner; J M Sodetz
Journal:  Biochemistry       Date:  1984-08-28       Impact factor: 3.162

6.  Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack.

Authors:  A K Campbell; B P Morgan
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

7.  Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.

Authors:  F Niculescu; F Hugo; H G Rus; R Vlaicu; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

8.  The activation of human complement component C5 by a fluid phase C5 convertase.

Authors:  R G DiScipio; C A Smith; H J Muller-Eberhard; T E Hugli
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

9.  Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts.

Authors:  W H Moolenaar; R Y Tsien; P T van der Saag; S W de Laat
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

10.  C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.

Authors:  Z Fishelson; H J Müller-Eberhard
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

View more
  40 in total

1.  Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis.

Authors:  S Kraus; R Seger; Z Fishelson
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 2.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 3.  The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription.

Authors:  Matthew Fosbrink; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Accelerated tumor growth mediated by sublytic levels of antibody-induced complement activation is associated with activation of the PI3K/AKT survival pathway.

Authors:  Xiaohong Wu; Govind Ragupathi; Katherine Panageas; Feng Hong; Philip O Livingston
Journal:  Clin Cancer Res       Date:  2013-07-05       Impact factor: 12.531

5.  Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up study.

Authors:  Jakob A Østergaard; Steffen Thiel; Peter Hovind; Charlotte B Holt; Hans-Henrik Parving; Allan Flyvbjerg; Peter Rossing; Troels K Hansen
Journal:  Diabetologia       Date:  2014-07-28       Impact factor: 10.122

6.  Depletion of intracellular Ca2+ stores, phosphorylation of eIF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole.

Authors:  H Aktas; R Flückiger; J A Acosta; J M Savage; S S Palakurthi; J A Halperin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

7.  CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.

Authors:  Guipeng An; Takashi Miwa; Wen-Liang Song; John A Lawson; Daniel J Rader; Yun Zhang; Wen-Chao Song
Journal:  Mol Immunol       Date:  2009-03-17       Impact factor: 4.407

Review 8.  The role of complement activation in atherosclerosis.

Authors:  Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

9.  Generation and phenotyping of mCd59a and mCd59b double-knockout mice.

Authors:  Xuebin Qin; Weiguo Hu; Wenping Song; Luciano Grubissich; Xuemei Hu; Gongxiong Wu; Sean Ferris; Martin Dobarro; Jose A Halperin
Journal:  Am J Hematol       Date:  2009-02       Impact factor: 10.047

10.  Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis.

Authors:  Cornelia Cudrici; Takahiro Ito; Ekaterina Zafranskaia; Susanna Weerth; Violeta Rus; Hegang Chen; Florin Niculescu; Katerina Soloviova; Cosmin Tegla; Adrian Gherman; Cedric S Raine; Moon L Shin; Horea Rus
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.